Please login to the form below

market landscape

This page shows the latest market landscape news and features for those working in and with pharma, biotech and healthcare.

The Communiqué Awards at 20: Sarah Matthew

Without doubt, the nature of the work we do. The market landscape in which we work has changed dramatically over this time which in turn has profoundly shaped both what we

Latest news

A new decade of disruption: meeting the biosimilar challgenge

A recent comprehensive European analysis confirms a poor correlation between market share and price. ... Preparation will be key to understanding the many complex factors that influence the adoption of biosimilars and, critically, to building an accurate
Access to orphan drugs for rare cancers in EU28

CUP helps facilitate a smoother transition of orphan drugs from clinical trials to market, and also helps companies as they develop global launch strategies for global usage patterns and market landscape ... predictions. In addition, market authorisation
Overriding the main frame

Starting a patient support project with a synthesis of the market landscape that includes relevant input from key internal stakeholders will help align the team from the outset. ... They are thought through, grounded in real market insight and built on a
The UK's new Cancer Drugs Fund

"Clearer, faster decision-making" promised. The recent unveiling of the new Cancer Drugs Fund (CDF) in the UK marked a major shift in the market access landscape, but it's one
Europe's market access outlook

An ever-closer union? Surveying Europe's market access landscape, the trend for cross-border collaboration looks set to continue, but there are significant changes ahead as some of the ... Germany prepares for significant change. Notwithstanding growing

More from news
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest Intelligence

Digital applications are transforming the market access landscape

With the rapidly evolving market access landscape, we are now on the cusp of a huge acceleration in the use of digital applications to explore value options, gain strategic advantage and ... New cloud technology provides an improved framework for
Customer experience rules the digital age

But are these traditionally linear models enough in an ever-evolving healthcare market landscape that is being so radically transformed in the digital age? ... Adding value. Within the pharmaceutical industry today, companies are re-orientating to a more
Assessing early market opportunity

a successful market assessment strategy. ... It will look at how marketers can understand the competitive market landscape as early as possible.
Getting below the surface: regional and local market access

In Germany, there are regional and local regulations in addition to the centralised market access regulations. ... This needs to be factored in as early as possible during the drug development pipeline, starting with close analysis of the local and
Interview: Kay Drake and Naoki Okamura, Astellas

Astellas’ vice president of marketing, Europe and its chief strategy officer, Europe discuss category leadership, the changing landscape of market access and growth in a time of austerity. ... Changing landscape. As the European payer landscape evolves

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

Kantar’s Gracie van Kemenade appointed quantitative director at Insight Research Group

She is joined at the market research company by fellow new recruit Paul O'Meara, who has been appointed regional head of syndicated studies. ... In addition, van Kemenade has experience in market landscape, target product profiling, patient record studies

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Top 5 tips for a multi-indication product launch

This involves planning activities like a situation analysis to understand the treatment landscape, market-shaping, awareness campaigns, development of a brand launch strategy, brand messaging, and customer-facing tactics. ... Today, it is more common to
White paper for download: Maintaining market access continuity through a global pandemic

In a Valid Insight webinar, we brought together key stakeholders to discuss the global coronavirus (COVID-19) pandemic and its effects on pharmaceutical pricing and market access. ... Preparing for a post-COVID-19 future in market access, including how
How ready are you for launch?

However, for pharmaceutical companies this means increased competition in an already crowded market place, making the launch landscape far more complex. ... This includes pivoting to keep up with market fluctuations and anticipating the competition.
Four recommendations to kick-start the digital transformation of your market access processes

I am witnessing a growing appreciation of new technology as a strategic asset within market access. ... Our tailored services include a suite of digital applications that transform market access processes.
News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)

In addition from Q1 2019 Therapy Watch will now be tracking prescription topical treatments in both a secondary care and primary care setting providing broad visibility of the psoriasis market landscape.

More from PMHub
Approximately 1 fully matching, plus 17 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....